Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oesophagogastric Cancer”

229 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 229 results

Testing effectiveness (Phase 2)Study completedNCT00165464
What this trial is testing

Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric CancerGE Junction Cancer
Dana-Farber Cancer Institute 54
Testing effectiveness (Phase 2)Study completedNCT01123811
What this trial is testing

Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer

Who this might be right for
Adenocarcinoma of Stomach or Esophagogastric Junction
Johannes Gutenberg University Mainz 45
Testing effectiveness (Phase 2)UnknownNCT06198465
What this trial is testing

Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma

Who this might be right for
AdebrelimabEsophageal CancerPerioperative Period
Xijing Hospital 24
Not applicableWithdrawnNCT05001360
What this trial is testing

Study of FMT Combined With Nivolumab in Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaEsophagogastric Junction AdenocarcinomaEsophagus Adenocarcinoma
Fujian Cancer Hospital
Not applicableLooking for participantsNCT06713993
What this trial is testing

Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer

Who this might be right for
Esophageal Cancer (EsC)
Semmelweis University 100
Not applicableUnknownNCT02418052
What this trial is testing

Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIE

Who this might be right for
Esophageal NeoplasmsEsophagectomyAnastomotic Leak
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 60
Not applicableStudy completedNCT05281380
What this trial is testing

VITAMin Insufficiency in Esophagogastric Neoplasms

Who this might be right for
Esophageal CancerGastric CancerVitamin Disease+1 more
Zuyderland Medisch Centrum 107
Not applicableLooking for participantsNCT06300879
What this trial is testing

A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique

Who this might be right for
Gastric CancerAdenocarcinoma of Esophagogastric Junction
Huashan Hospital 30
Early research (Phase 1)Looking for participantsNCT06623396
What this trial is testing

Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Who this might be right for
Mesothelin PositiveMesothelin-Expressing TumorsEsophageal Adenocarcinoma+5 more
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00719550
What this trial is testing

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Who this might be right for
Esophagogastric Junction AdenocarcinomaGastric CancerEsophageal Cancer
Amgen 130
Not applicableNot Yet RecruitingNCT07067359
What this trial is testing

The Intensive Nutritional Support in Esophageal Cancer Undergoing Neoadjuvant Therapy

Who this might be right for
Esophageal Cancer
Sichuan University 200
Testing effectiveness (Phase 2)Study completedNCT02406170
What this trial is testing

Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsNeoplasm Metastasis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 47
Testing effectiveness (Phase 2)Study completedNCT00137813
What this trial is testing

Avastin and Taxotere for Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Dana-Farber Cancer Institute 42
Testing effectiveness (Phase 2)UnknownNCT04442984
What this trial is testing

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)

Who this might be right for
Gastric Carcinoma Stage IVEsophagogastric Junction Adenocarcinoma Stage IV
Blokhin's Russian Cancer Research Center 326
Testing effectiveness (Phase 2)Looking for participantsNCT07018570
What this trial is testing

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastroesophageal Junction (GEJ) Adenocarcinoma
National Cancer Center Hospital East 26
Not applicableStudy completedNCT02023996
What this trial is testing

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Who this might be right for
Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center 42
Large-scale testing (Phase 3)Active Not RecruitingNCT05180734
What this trial is testing

PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

Who this might be right for
Gastric or Esophagogastric Junction Adenocarcinoma
Shanghai Junshi Bioscience Co., Ltd. 878
Not applicableUnknownNCT04224363
What this trial is testing

Whether it is More Appropriate to Spray Lugol's Solution From Cervical Esophagus to Esophagogastric Junction

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shandong University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04757363
What this trial is testing

Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer

Who this might be right for
Esophagogastric CancerHER2-Negative
Memorial Sloan Kettering Cancer Center 39
Early research (Phase 1)UnknownNCT05315830
What this trial is testing

HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric

Who this might be right for
Adenocarcinoma - GEJAdenocarcinoma of the Stomach
The First Affiliated Hospital of Bengbu Medical University 10
Next Page